Michael Kranda
Experienced Life Science Executive, VC, and Consultant | Driving growth, innovation, and value for Patients and Shareholders | 10+ Board Roles | 5+ Products to Market
- Role
- Board Member, Chief Business Officer at Aclipse Therapeutics
- Location
- Seattle, WA, US
- LinkedIn followers
- 500 followers
About Michael Kranda
Background | Board & Product to Market Details | Skills | Patents Served in…
Experience
Board Member, Chief Business Officer
May 2023 — Present · King of Prussia, PA, US
Aclipse Therapeutics is a clinical stage company focused on molecular pathways that regulate cellular stress, protein misfolding and inflammation. We are currently developing two in-licensed clinical assets with 7 potential indications and existing $30 billion markets. M107 is primed to enter a Ph2 trial for the treatment of gastroparesis. M107 has the potential to modify the disease by restoring normal gastric pacemaker function.M102 is primed to enter a Ph 1 trial next year for the treatment of sporadic ALS and designed to activate both Nrf2 and HSF1 pathways. Further, we are developing biomarkers based on patient PBMCs to identify potential drug responders and exploring Parkinson’s and Friedreich’s Ataxia as potential additional indications.
Education
University of Washington
MBA, Finance
1982 — 1984
Skills
- Pharmaceutical Industry
- Due Diligence
- Lifesciences
- Private Equity
- Valuation
- Life Sciences
- Venture Financing
- Mergers
- Commercialization
- Strategy
- Start-Ups
- Financial Modeling
- Technology Transfer
- Venture Capital
- Corporate Finance
- Business Strategy
- Mergers & Acquisitions
- Investor Relations
- Entrepreneurship
- Business Development
- Biotechnology
- Investments
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.